Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Gross Margin (2016 - 2017)

Historic Gross Margin for Lisata Therapeutics (LSTA) over the last 8 years, with Q1 2017 value amounting to 1.51%.

  • Lisata Therapeutics' Gross Margin fell 183500.0% to 1.51% in Q1 2017 from the same period last year, while for Mar 2017 it was 7.75%, marking a year-over-year increase of 273100.0%. This contributed to the annual value of 11.76% for FY2016, which is 14000.0% up from last year.
  • According to the latest figures from Q1 2017, Lisata Therapeutics' Gross Margin is 1.51%, which was down 183500.0% from 9.15% recorded in Q4 2016.
  • In the past 5 years, Lisata Therapeutics' Gross Margin registered a high of 19718.99% during Q3 2013, and its lowest value of 97334.9% during Q3 2014.
  • In the last 5 years, Lisata Therapeutics' Gross Margin had a median value of 7.58% in 2016 and averaged 22823.91%.
  • Per our database at Business Quant, Lisata Therapeutics' Gross Margin tumbled by -1170538900bps in 2014 and then surged by 973532300bps in 2015.
  • Lisata Therapeutics' Gross Margin (Quarter) stood at 18000.22% in 2013, then tumbled by -538bps to 78810.29% in 2014, then dropped by -4bps to 81682.29% in 2015, then soared by 100bps to 9.15% in 2016, then tumbled by -116bps to 1.51% in 2017.
  • Its Gross Margin was 1.51% in Q1 2017, compared to 9.15% in Q4 2016 and 7.58% in Q3 2016.